Shaanxi company independently develops high-end artificial intraocular lenses approved for market launch

On February 26, according to Xi’an Yandele Medical Technology Co., Ltd.: Recently, the company’s independently developed toric (astigmatism correction) intraocular lens has been approved for market launch by the National Medical Products Administration. This marks another innovative achievement for Shaanxi in the field of high-end intraocular lenses, providing more precise and personalized treatment options for patients with cataracts combined with corneal astigmatism, promoting the upgrade of cataract surgery from “seeing” to “seeing clearly and well,” and advancing the development of domestic ophthalmic implant devices toward high-end and precision. (Shaanxi Release)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin